HC Deb 10 November 2003 vol 413 cc130-1W
Mr. Paul Marsden

To ask the Secretary of State for Health how much was spent by his Department on research into diabetes in each year since 1997. [134395]

Ms Rosie Winterton

The Department has consistently supported research into diabetes but has not in the past collected information on its total expenditure in this field. The greater part of the funding meets the service costs to the national health service of research funded by research councils and charities, including Diabetes UK. This funding was identified for the first time from the NHS trust annual research and development reports for 2001–02, and the Department's total spend on diabetes research in that year has been estimated as £14.1 million.

Available estimates of Medical Research Council spend on diabetes research are shown in the table.

1999–2000 6.5
2000–01 8.6
2001–02 8.9

Judy Mallaber

To ask the Secretary of State for Health pursuant to his answer of 29 October,Official Report, column. 234W, on diabetes, which companies have confirmed that they will continue to supply animal insulin for diabetics; and what written commitments they have made. [136779]

Ms Rosie Winterton

Novo Nordisk and CP Pharmaceuticals market animal insulins. Novo Nordisk informed the Department that they would be continuing to supply animal insulins to the United Kingdom market for the foreseeable future. CP Pharmaceuticals issued a press release in July this year confirming that they would be continuing to supply animal insulins. Both companies have recently confirmed that their position remains unchanged.

Forward to